• Menu
  • Skip to right header navigation
  • Skip to main content

Isosceles Pharmaceuticals, Inc.

A New Angle on Non-opioid Pain Relief

  • Home
  • About Us
  • Team
  • Pipeline
  • News
  • Contact Us
  • Home
  • About Us
  • Team
  • Pipeline
  • News
  • Contact Us

Isosceles Pharmaceuticals appoints Herbert Neuman, MD, MBA Chief Medical Officer and adds Thomas Harrison, LH.D as a strategic advisor

September 14, 2021//  by Brett

Growing Isosceles Pharmaceuticals team pushes to develop novel, non-opioid products to treat acute pain Isosceles Pharmaceuticals welcomed two new team members – Herbert Neuman, MD, MBA, and Thomas L. Harrison LH.D – to their award-winning mission. The early-stage venture launched two years ago, setting out to formulate and commercialize products that effectively and safely treat …

Isosceles Pharmaceuticals appoints Herbert Neuman, MD, MBA Chief Medical Officer and adds Thomas Harrison, LH.D as a strategic advisorRead More

Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer

May 5, 2021//  by Brett

Seasoned pharmaceutical executive with more than 30 years of Commercial and Business Strategy experience Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to developing, commercializing, and marketing innovative non-opioid products for the treatment of mild to moderate pain and inflammatory diseases, today announced the appointment of William D. Humphries as its Chief Executive Officer. Mr. Humphries …

Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive OfficerRead More

Copyright © 2023 · Isosceles Pharmaceuticals, Inc.